<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pauly MG</submitter><funding>Damp Foundation</funding><funding>German Research Foundation</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Medical Research Council</funding><funding>European Union Seventh Framework Programme</funding><funding>European Union’s Horizon 2020</funding><funding>“Gutes tun”</funding><pagination>1874</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9953040</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(3)</volume><pubmed_abstract>&lt;i>VPS13D&lt;/i> is one of four human homologs of the &lt;i>vacuolar sorting protein 13&lt;/i> gene (&lt;i>VPS13&lt;/i>). Biallelic pathogenic variants in the gene are associated with spastic ataxia or spastic paraplegia. Here, we report two patients with intronic pathogenic variants: one patient with early onset severe spastic ataxia and debilitating tremor, which is compound-heterozygous for a canonical (NM_018156.4: c.2237-1G > A) and a non-canonical (NM_018156.4: c.941+3G>A) splice site variant. The second patient carries the same non-canonical splice site variant in the homozygous state and is affected by late-onset spastic paraplegia. We confirmed altered splicing as a result of the intronic variants and demonstrated disturbed mitochondrial integrity. Notably, tremor in the first patient improved s</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Not to Miss: Intronic Variants, Treatment, and Review of the Phenotypic Spectrum in &lt;i>VPS13D&lt;/i>-Related Disorder.</pubmed_title><pmcid>PMC9953040</pmcid><funding_grant_id>DFG-GEPRIS 413535489</funding_grant_id><funding_grant_id>469177153</funding_grant_id><funding_grant_id>779257</funding_grant_id><funding_grant_id>305444</funding_grant_id><funding_grant_id>MR/S005021/1′</funding_grant_id><funding_grant_id>MR/S005021/1</funding_grant_id><funding_grant_id>n. a.</funding_grant_id><funding_grant_id>BR4328.2-1</funding_grant_id><pubmed_authors>Grozinger A</pubmed_authors><pubmed_authors>Houlden H</pubmed_authors><pubmed_authors>Lohmann K</pubmed_authors><pubmed_authors>Pauly MG</pubmed_authors><pubmed_authors>Turchetti V</pubmed_authors><pubmed_authors>Munchau A</pubmed_authors><pubmed_authors>Bruggemann N</pubmed_authors><pubmed_authors>Tadic V</pubmed_authors><pubmed_authors>Efthymiou S</pubmed_authors><pubmed_authors>Diaw SH</pubmed_authors><pubmed_authors>Vona B</pubmed_authors><pubmed_authors>Chelban V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Not to Miss: Intronic Variants, Treatment, and Review of the Phenotypic Spectrum in &lt;i>VPS13D&lt;/i>-Related Disorder.</name><description>&lt;i>VPS13D&lt;/i> is one of four human homologs of the &lt;i>vacuolar sorting protein 13&lt;/i> gene (&lt;i>VPS13&lt;/i>). Biallelic pathogenic variants in the gene are associated with spastic ataxia or spastic paraplegia. Here, we report two patients with intronic pathogenic variants: one patient with early onset severe spastic ataxia and debilitating tremor, which is compound-heterozygous for a canonical (NM_018156.4: c.2237-1G > A) and a non-canonical (NM_018156.4: c.941+3G>A) splice site variant. The second patient carries the same non-canonical splice site variant in the homozygous state and is affected by late-onset spastic paraplegia. We confirmed altered splicing as a result of the intronic variants and demonstrated disturbed mitochondrial integrity. Notably, tremor in the first patient improved s</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-21T17:25:31.151Z</modification><creation>2024-12-04T12:38:33.142Z</creation></dates><accession>S-EPMC9953040</accession><cross_references><pubmed>36768210</pubmed><doi>10.3390/ijms24031874</doi></cross_references></HashMap>